153 related articles for article (PubMed ID: 27587602)
1. Diuretics prevent Rho-kinase activation and expression of profibrotic/oxidative genes in the hypertensive aortic wall.
Araos P; Mondaca D; Jalil JE; Yañez C; Novoa U; Mora I; Ocaranza MP
Ther Adv Cardiovasc Dis; 2016 Dec; 10(6):338-347. PubMed ID: 27587602
[TBL] [Abstract][Full Text] [Related]
2. Hydrochlorothiazide Reduces Cardiac Hypertrophy, Fibrosis and Rho-Kinase Activation in DOCA-Salt Induced Hypertension.
Mondaca-Ruff D; Araos P; Yañez CE; Novoa UF; Mora IG; Ocaranza MP; Jalil JE
J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):724-735. PubMed ID: 34623176
[TBL] [Abstract][Full Text] [Related]
3. Rho kinase activation and gene expression related to vascular remodeling in normotensive rats with high angiotensin I converting enzyme levels.
Rivera P; Ocaranza MP; Lavandero S; Jalil JE
Hypertension; 2007 Oct; 50(4):792-8. PubMed ID: 17785632
[TBL] [Abstract][Full Text] [Related]
4. Rho kinase activation in circulating leukocytes is related to hypertensive myocardial remodeling.
Ocaranza MP; Fierro C; Jalil JE; Moya J; Gonzalez L; Molina C; Mancilla C
Clin Sci (Lond); 2018 Aug; 132(16):1837-1853. PubMed ID: 30065083
[TBL] [Abstract][Full Text] [Related]
5. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, ameliorates hepatic fibrosis in rats with type 2 diabetes.
Zhou H; Fang C; Zhang L; Deng Y; Wang M; Meng F
Chin Med J (Engl); 2014; 127(2):225-31. PubMed ID: 24438608
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous Rho kinase inhibition in circulating leukocytes and in cardiovascular tissue in rats with high angiotensin converting enzyme levels.
Fierro C; Novoa U; González V; Ocaranza MP; Jalil JE
Int J Cardiol; 2016 Jul; 215():309-17. PubMed ID: 27128553
[TBL] [Abstract][Full Text] [Related]
7. Endothelin receptor blockade ameliorates renal injury by inhibition of RhoA/Rho-kinase signalling in deoxycorticosterone acetate-salt hypertensive rats.
Lee TM; Chung TH; Lin SZ; Chang NC
J Hypertens; 2014 Apr; 32(4):795-805. PubMed ID: 24463935
[TBL] [Abstract][Full Text] [Related]
8. The Role of the Rho/ROCK Pathway in Ang II and TGF-β1-Induced Atrial Remodeling.
Liu LJ; Yao FJ; Lu GH; Xu CG; Xu Z; Tang K; Cheng YJ; Gao XR; Wu SH
PLoS One; 2016; 11(9):e0161625. PubMed ID: 27611832
[TBL] [Abstract][Full Text] [Related]
9. Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats.
Koshikawa S; Nishikimi T; Inaba C; Akimoto K; Matsuoka H
J Hypertens; 2008 Sep; 26(9):1837-48. PubMed ID: 18698220
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective mechanisms of spironolactone associated with the angiotensin-converting enzyme/epidermal growth factor receptor/extracellular signal-regulated kinases, NAD(P)H oxidase/lectin-like oxidized low-density lipoprotein receptor-1, and Rho-kinase pathways in aldosterone/salt-induced hypertensive rats.
Nakano S; Kobayashi N; Yoshida K; Ohno T; Matsuoka H
Hypertens Res; 2005 Nov; 28(11):925-36. PubMed ID: 16555582
[TBL] [Abstract][Full Text] [Related]
11. TGF-β1 promotes pulmonary arterial hypertension in rats via activating RhoA/ROCK signaling pathway.
Zhang Y; Yuan RX; Bao D
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4988-4996. PubMed ID: 32432762
[TBL] [Abstract][Full Text] [Related]
12. Long-term administration of rho-kinase inhibitor ameliorates renal damage in malignant hypertensive rats.
Ishikawa Y; Nishikimi T; Akimoto K; Ishimura K; Ono H; Matsuoka H
Hypertension; 2006 Jun; 47(6):1075-83. PubMed ID: 16636194
[TBL] [Abstract][Full Text] [Related]
13. Alkaloids from Nelumbinis Plumula (AFNP) ameliorate aortic remodeling via RhoA/ROCK pathway.
Li Q; Wo D; Huang Y; Yu N; Zeng J; Chen H; Wang H; Bao L; Lin S; Chu J; Peng J
Biomed Pharmacother; 2019 Apr; 112():108651. PubMed ID: 30784931
[TBL] [Abstract][Full Text] [Related]
14. Increased rho-kinase activity in hypertensive patients with left ventricular hypertrophy.
Gabrielli L; Winter JL; Godoy I; McNab P; Padilla I; Cordova S; Rigotti P; Novoa U; Mora I; García L; Ocaranza MP; Jalil JE
Am J Hypertens; 2014 Jun; 27(6):838-45. PubMed ID: 24363278
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1.
Li Q; Xu Y; Li X; Guo Y; Liu G
Toxicol Lett; 2012 Jun; 211(2):91-7. PubMed ID: 22465603
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice.
Cao X; Luo T; Luo X; Tang Z
Hypertens Res; 2014 Sep; 37(9):803-10. PubMed ID: 24965170
[TBL] [Abstract][Full Text] [Related]
17. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways.
Wang N; Guan P; Zhang JP; Li YQ; Chang YZ; Shi ZH; Wang FY; Chu L
J Cell Biochem; 2011 Jul; 112(7):1920-9. PubMed ID: 21433064
[TBL] [Abstract][Full Text] [Related]
18. Air pollution exposure potentiates hypertension through reactive oxygen species-mediated activation of Rho/ROCK.
Sun Q; Yue P; Ying Z; Cardounel AJ; Brook RD; Devlin R; Hwang JS; Zweier JL; Chen LC; Rajagopalan S
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1760-6. PubMed ID: 18599801
[TBL] [Abstract][Full Text] [Related]
19. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension.
Gómez-Guzmán M; Jiménez R; Sánchez M; Zarzuelo MJ; Galindo P; Quintela AM; López-Sepúlveda R; Romero M; Tamargo J; Vargas F; Pérez-Vizcaíno F; Duarte J
Free Radic Biol Med; 2012 Jan; 52(1):70-9. PubMed ID: 22001745
[TBL] [Abstract][Full Text] [Related]
20. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling.
Martins-Oliveira A; Castro MM; Oliveira DM; Rizzi E; Ceron CS; Guimaraes D; Reis RI; Costa-Neto CM; Casarini DE; Ribeiro AA; Gerlach RF; Tanus-Santos JE
Int J Cardiol; 2013 Aug; 167(4):1199-205. PubMed ID: 22483258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
